Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis.
autoimmune disease
microarray
myomiRs
polymyositis
Journal
EJIFCC
ISSN: 1650-3414
Titre abrégé: EJIFCC
Pays: Italy
ID NLM: 101092742
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
entrez:
3
8
2019
pubmed:
3
8
2019
medline:
3
8
2019
Statut:
epublish
Résumé
MicroRNA (miRNA) research has intensively developed over the past decade. Characterization of dysregulated miRNA expression profiles could give a better understanding of the development of pathological conditions and clinical disorders, such as autoimmune diseases with polygenic etiology, including idiopathic inflammatory myopathies (IIMs). IIMs are a group of rare autoimmune disorders characterized by skeletal weakness and inflammation. Polymyositis (PM) is one of the conditions of autoimmune myopathies with proximal skeletal muscle weakness. A novel group of miRNAs, known as myomiRs are described as striated muscle-specific or muscle-enriched miRNAs. They are involved in myoblast proliferation/differentiation as well as muscle regeneration. To determine the role of myomiRs in the development and progression of PM, we performed an initial skeletal muscle miRNA profiling using microarray technique at diagnosis. The aim of the study was to examine myomiRs expression profile in patients with PM in order to remark the association between the dysregulated myomiRs' expression and the development of the disease. As a results of microarray investigation, most of the myomiRs showed altered expression patterns in the muscle samples of PM patients compared to controls. These results suggest that myomiRs, especially miR-1, miR-133a, miR-208b, miR-486, and miR-499 function in a network, and are associated with the development of PM.
Types de publication
Journal Article
Langues
eng
Pagination
237-245Références
N Engl J Med. 1975 Feb 13;292(7):344-7
pubmed: 1090839
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Curr Opin Genet Dev. 2005 Oct;15(5):528-35
pubmed: 16055324
Nat Genet. 2006 Feb;38(2):228-33
pubmed: 16380711
J Cell Biol. 2006 Aug 28;174(5):677-87
pubmed: 16923828
Biochim Biophys Acta. 2008 Nov;1779(11):682-91
pubmed: 18381085
Arthritis Rheum. 2008 May;58(5):1284-92
pubmed: 18438844
Arthritis Res Ther. 2008;10(4):R101
pubmed: 18759964
Curr Opin Mol Ther. 2009 Apr;11(2):189-99
pubmed: 19330724
Arthritis Rheum. 2009 Apr;60(4):1065-75
pubmed: 19333922
Physiol Genomics. 2009 Nov 6;39(3):219-26
pubmed: 19690046
Nat Immunol. 2009 Dec;10(12):1252-9
pubmed: 19838199
Int J Biochem Cell Biol. 2010 Aug;42(8):1252-5
pubmed: 20619221
J Physiol. 2010 Nov 1;588(Pt 21):4075-87
pubmed: 20724363
Exerc Sport Sci Rev. 2011 Jul;39(3):150-4
pubmed: 21467943
Immunol Lett. 2012 Jan 30;141(2):165-8
pubmed: 22033216
Arthritis Rheumatol. 2014 Apr;66(4):1022-33
pubmed: 24757153
Autoimmun Rev. 2014 Dec;13(12):1211-9
pubmed: 25182203
Curr Opin Rheumatol. 2015 Nov;27(6):608-15
pubmed: 26398013
Int J Rheum Dis. 2017 May;20(5):609-613
pubmed: 26620207
Dev Biol. 2016 Feb 1;410(1):1-13
pubmed: 26708096
J Neuromuscul Dis. 2015;2(1):1-11
pubmed: 27547731
PLoS One. 2017 Mar 24;12(3):e0174585
pubmed: 28339495
Ann Rheum Dis. 2017 Dec;76(12):1955-1964
pubmed: 29079590
Inflamm Regen. 2018 Jan 8;38:1
pubmed: 29321815